Search Results - "Baronzio, Gianfranco"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Hyperthermia and Immunity. A Brief Overview by Baronzio, Gianfranco, Gramaglia, Alberto, Fiorentini, Gianmaria

    Published in In vivo (Athens) (01-11-2006)
    “…After many years, hyperthermia (HT) is experiencing a new resurgence as seen by the positive results of many randomized trials all over the world. Tumour…”
    Get full text
    Journal Article
  3. 3

    Current Role and Future Perspectives of Hyperthermia for Prostate Cancer Treatment by GIANFRANCO BARONZIO, ALBERTO GRAMAGLIA, GIANMARIA FIORENTINI

    Published in In vivo (Athens) (01-01-2009)
    “…Prostate cancer is the second most common cause of death in men. Between 10% -60% of patients experience biochemical recurrence associated with treatment…”
    Get full text
    Journal Article
  4. 4

    Update on the challenges and recent advances in cancer immunotherapy by Baronzio, Gianfranco, Parmar, Gurdev, Shubina, Irina Zh, Cassutti, Valter, Giuli, Sergio, Ballerini, Marco, Kiselevsky, Mikhail

    Published in ImmunoTargets and therapy (01-01-2013)
    “…This overview provides an analysis of some of the immunotherapies currently in use and under investigation, with a special focus on the tumor microenvironment,…”
    Get full text
    Journal Article
  5. 5

    Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid by Baronzio, Gianfranco, Parmar, Gurdev, Baronzio, Miriam

    Published in Frontiers in oncology (23-07-2015)
    “…Every drug used to treat cancer (chemotherapeutics, immunological, monoclonal antibodies, nanoparticles, radionuclides) must reach the targeted cells through…”
    Get full text
    Journal Article
  6. 6

    Tumor interstitial fluid: proteomic determination as a possible source of biomarkers by Baronzio, Gianfranco, Parmar, Gurdev, Baronzio, Miriam, Kiselevsky, Mikhail

    Published in Cancer genomics & proteomics (01-09-2014)
    “…Tumor interstitial fluid (TIF) is formed largely by an imbalance between the forces that govern the filtration of liquid between the luminal and abluminal…”
    Get full text
    Journal Article
  7. 7

    Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis by Baronzio, Gianfranco, Schwartz, Laurent, Kiselevsky, Mikhail, Guais, Adeline, Sanders, Edward, Milanesi, Gloria, Baronzio, Miriam, Freitas, Isabel

    Published in Anticancer research (01-02-2012)
    “…Tumor interstitial fluid (TIF) is a watery phase that accumulates inside the tumor interstitium. Its genesis and fate depend on various factors, namely tumor…”
    Get full text
    Journal Article
  8. 8

    Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin by Schwartz, Laurent, Guais, Adeline, Israël, Maurice, Junod, Bernard, Steyaert, Jean-Marc, Crespi, Elisabetta, Baronzio, Gianfranco, Abolhassani, Mohammad

    Published in Investigational new drugs (01-04-2013)
    “…Summary Cellular metabolic alterations are now well described as implicated in cancer and some strategies are currently developed to target these different…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Review. Current role and future perspectives of hyperthermia for prostate cancer treatment by Baronzio, Gianfranco, Gramaglia, Alberto, Fiorentini, Gianmaria

    Published in In vivo (Athens) (01-01-2009)
    “…Prostate cancer is the second most common cause of death in men. Between 10%-60% of patients experience biochemical recurrence associated with treatment…”
    Get full text
    Journal Article
  11. 11

    Is it necessary to deplete the lymphokine activated killers’ populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killers by Chikileva, Irina Olegovna, Shubina, Irina Z, Baronzio, Gianfranco, Kiselevsky, Mikhail V

    Published in Biomedicine & pharmacotherapy (01-07-2010)
    “…Abstract LAKs are used in cancer therapy. A common argument against LAK therapy is the probability of the activation of Tregs by IL-2 alongside with NK cells…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/[beta]-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers by Natalia Yu. Anisimova, Sosnov, Andrey V, Ustyuzhanina, Nadezhda E, Baronzio, Gianfranco, Kiselevsky, Mikhail V

    Published in ISRN oncology (01-01-2011)
    “…Nanocomposition comprised of interleukin-2 in suboptimal noneffective concentration and β-cyclodextrin was studied in vitro. This preparation as well as…”
    Get full text
    Journal Article
  14. 14

    Tumor microenvironment and hemorheological abnormalities by Baronzio, Gianfranco, Freitas, Isabel, Kwaan, Hau C

    Published in Seminars in thrombosis and hemostasis (01-10-2003)
    “…This article reviews the various mechanisms in a malignant tumor that lead to hypoxia, production of tumor interstitial fluid, and rheological changes in its…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers by Baronzio, Gianfranco, Sosnov, Andrey V., Ustyuzhanina, Nadezhda E., Kiselevsky, Mikhail V., Anisimova, Natalia Yu

    Published in ISRN oncology (01-01-2011)
    “…Nanocomposition comprised of interleukin-2 in suboptimal noneffective concentration and β-cyclodextrin was studied in vitro. This preparation as well as…”
    Get full text
    Journal Article
  17. 17

    Stem cell recruitment and liver de-differentiation in MMTV-neu (ErbB-2) transgenic mice by Freitas, Isabel, Fracchiolla, Simona, Baronzio, Gianfranco, Griffini, Patrizia, Bertone, Roberta, Sitar, Gian Maria, Barni, Sergio, Gerzeli, Giuseppe, Sacco, Maria Grazia

    Published in Anticancer research (01-09-2003)
    “…The liver of tumor-bearing hosts manifests fetal phenotypes. We investigated the expression of differentiation markers on the liver in MMTV-neu (ErbB-2)…”
    Get more information
    Journal Article
  18. 18

    Proinflammatory and regulatory cytokine levels in AIDS cachexia by Baronzio, G, Zambelli, A, Comi, D, Barlocco, A, Baronzio, A, Marchesi, P, Gramaglia, A, Castiglioni, E, Mafezzoni, A, Beviglia, E, Crespi, F, Cargnel, A I, Pravettoni, G

    Published in In vivo (Athens) (01-11-1999)
    “…The serum concentrations of inflammatory (Interleukin-1 beta, Tumor necrosis alpha, Interleukin-6) and regulatory cytokines (Interleukin twelve) have been…”
    Get more information
    Journal Article